Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Return on Invested Capital: 2024-2025

Historic Return on Invested Capital for Sunshine Biopharma (SBFM) over the last 2 years, with Sep 2025 value amounting to 0.24%.

  • Sunshine Biopharma's Return on Invested Capital was N/A to 0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24%, marking a year-over-year change of. This contributed to the annual value of 0.25% for FY2024, which is N/A change from last year.
  • As of Q3 2025, Sunshine Biopharma's Return on Invested Capital stood at 0.24%, which was up 8.66% from 0.26% recorded in Q2 2025.
  • Sunshine Biopharma's Return on Invested Capital's 5-year high stood at 0.19% during Q2 2024, with a 5-year trough of 0.26% in Q2 2025.